Ken Griffin Cardiol Therapeutics Inc. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2025 May 15, 2025	SELL	$0.96 - $1.46 $2,016 - $3,066	-2,100 Reduced 55.26%	1,700 $1,000
Q4 2024 Feb 14, 2025	SELL	$1.25 - $2.07 $7,125 - $11,798	-5,700 Reduced 60.0%	3,800 $4,000
Q3 2024 Nov 14, 2024	BUY	$1.83 - $2.48 $3,843 - $5,208	2,100 Added 28.38%	9,500 $18,000
Q2 2024 Aug 14, 2024	BUY	$1.67 - $2.97 $12,358 - $21,978	7,400 New	7,400 $14,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.0 $670 - $1,000	1,000 New	1,000 $0
Q4 2022 Feb 14, 2023	BUY	$0.48 - $1.0 $768 - $1,600	1,600 New	1,600 $0

7.81M

25.9K

1.7K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $76.8M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.